↓ Skip to main content

Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO…

Overview of attention for article published in BMC Cancer, March 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

blogs
1 blog
patent
4 patents

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial
Published in
BMC Cancer, March 2018
DOI 10.1186/s12885-018-4197-9
Pubmed ID
Authors

Susen Burock, Severin Daum, Ulrich Keilholz, Konrad Neumann, Wolfgang Walther, Ulrike Stein

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 73 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 19%
Student > Bachelor 10 14%
Student > Ph. D. Student 7 10%
Student > Master 6 8%
Other 4 5%
Other 8 11%
Unknown 24 33%
Readers by discipline Count As %
Medicine and Dentistry 16 22%
Agricultural and Biological Sciences 7 10%
Biochemistry, Genetics and Molecular Biology 6 8%
Nursing and Health Professions 4 5%
Psychology 3 4%
Other 6 8%
Unknown 31 42%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 August 2022.
All research outputs
#3,685,260
of 22,558,544 outputs
Outputs from BMC Cancer
#877
of 8,206 outputs
Outputs of similar age
#68,404
of 299,779 outputs
Outputs of similar age from BMC Cancer
#1
of 1 outputs
Altmetric has tracked 22,558,544 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,206 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 299,779 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them